Patents by Inventor Jer-Yuan Hsu

Jer-Yuan Hsu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240043533
    Abstract: The present disclosure provides binding agents, such as antibodies, that specifically bind ILT3, including human ILT3, as well as compositions comprising the binding agents, and methods of their use. The disclosure also provides related polynucleotides and vectors encoding the binding agents and cells comprising the binding agents.
    Type: Application
    Filed: August 2, 2023
    Publication date: February 8, 2024
    Inventors: Suzanne Christine Crawley, Jer-Yuan Hsu, Daniel David Kaplan, Betty Chan Li, Vicky Yi-Bing Lin, Seth Malmersjö, Kevin James Paavola, Julie Michelle Roda, Yan Wang
  • Patent number: 11760802
    Abstract: The present disclosure provides binding agents, such as antibodies, that specifically bind ILT3, including human ILT3, as well as compositions comprising the binding agents, and methods of their use. The disclosure also provides related polynucleotides and vectors encoding the binding agents and cells comprising the binding agents.
    Type: Grant
    Filed: December 17, 2020
    Date of Patent: September 19, 2023
    Assignee: NGM Biopharmaceuticals, Inc.
    Inventors: Suzanne Christine Crawley, Jer-Yuan Hsu, Daniel David Kaplan, Betty Chan Li, Vicky Yi-Bing Lin, Seth Malmersjö, Kevin James Paavola, Julie Michelle Roda, Yan Wang
  • Patent number: 11358995
    Abstract: Methods of treating individuals with a glucose metabolism disorder and/or a body weight disorder, and compositions associated therewith, are provided.
    Type: Grant
    Filed: February 7, 2020
    Date of Patent: June 14, 2022
    Assignee: NGM Biopharmaceuticals, Inc.
    Inventors: Darrin Anthony Lindhout, Raj Haldankar, Hui Tian, Jer-Yuan Hsu
  • Publication number: 20210221887
    Abstract: The present disclosure provides binding agents, such as antibodies, that specifically bind ILT3, including human ILT3, as well as compositions comprising the binding agents, and methods of their use. The disclosure also provides related polynucleotides and vectors encoding the binding agents and cells comprising the binding agents.
    Type: Application
    Filed: December 17, 2020
    Publication date: July 22, 2021
    Inventors: Suzanne Christine Crawley, Jer-Yuan Hsu, Daniel David Kaplan, Betty Chan Li, Vicky Yi-Bing Lin, Seth Malmersjö, Kevin James Paavola, Julie Michelle Roda, Yan Wang
  • Publication number: 20210198366
    Abstract: The present disclosure provides binding agents, such as antibodies, that specifically bind B7-H7, including human B7-H7, as well as compositions comprising the binding agents and methods of their use. The disclosure also provides related polynucleotides and vectors encoding the binding agents and cells comprising the binding agents.
    Type: Application
    Filed: August 20, 2019
    Publication date: July 1, 2021
    Inventors: Jer-Yuan Hsu, Suzanne Christine Crawley
  • Publication number: 20200165314
    Abstract: Methods of treating individuals with a glucose metabolism disorder and/or a body weight disorder, and compositions associated therewith, are provided.
    Type: Application
    Filed: February 7, 2020
    Publication date: May 28, 2020
    Inventors: Darrin Anthony Lindhout, Raj Haldankar, Hui Tian, Jer-Yuan Hsu
  • Publication number: 20180134761
    Abstract: Methods of treating individuals with a glucose metabolism disorder and/or a body weight disorder, and compositions associated therewith, are provided.
    Type: Application
    Filed: November 1, 2017
    Publication date: May 17, 2018
    Inventors: Darrin Anthony Lindhout, Raj Haldankar, Hui Tian, Jer-Yuan Hsu
  • Patent number: 9834586
    Abstract: Methods of treating individuals with a glucose metabolism disorder and/or a body weight disorder, and compositions associated therewith, are provided.
    Type: Grant
    Filed: July 28, 2015
    Date of Patent: December 5, 2017
    Assignee: NGM Biopharmaceuticals, Inc.
    Inventors: Darrin Anthony Lindhout, Raj Haldankar, Hui Tian, Jer-Yuan Hsu
  • Publication number: 20170299608
    Abstract: The present disclosure provides a protein complex, including a three-dimensional structure of the protein complex, that plays a role in regulation of body weight. In addition, the protein complex and components thereof, including three-dimensional structures thereof, find use in identifying agents that can be used to control body weight.
    Type: Application
    Filed: March 3, 2017
    Publication date: October 19, 2017
    Inventors: Jer-Yuan HSU, Yu CHEN, Suzanne Christine CRAWLEY, Hui TIAN, Wenyan SHEN, Jie TANG, Jared Martin HIGBEE
  • Publication number: 20170081410
    Abstract: The present disclosure provides a composition comprising an agent that modulates binding of Vista to LRIG1; and further provides methods of modulating binding of Vista to LRIG1. The present disclosure provides a composition comprising an agent that modulates binding of HHLA2 to KIR3DL3; and further provides methods of modulating binding of HHLA2 to KIR3DL3.
    Type: Application
    Filed: May 19, 2015
    Publication date: March 23, 2017
    Inventors: Suzanne Christine Crawley, Jer-Yuan Hsu, Hui Tian
  • Publication number: 20160031960
    Abstract: Methods of treating individuals with a glucose metabolism disorder and/or a body weight disorder, and compositions associated therewith, are provided.
    Type: Application
    Filed: July 28, 2015
    Publication date: February 4, 2016
    Inventors: Darrin Anthony Lindhout, Raj Haldankar, Hui Tian, Jer-Yuan Hsu